{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:05:05Z","timestamp":1778796305561,"version":"3.51.4"},"reference-count":25,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2010,8,25]],"date-time":"2010-08-25T00:00:00Z","timestamp":1282694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lasers Surg Med"],"published-print":{"date-parts":[[2010,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Melasma is a uichronic, often relapsing skin disorder, with poor long\u2010term results from all current therapies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To assess efficacy and safety of non\u2010ablative 1,550\u2009nm fractional laser therapy (FLT) as compared to the gold standard, triple topical therapy (TTT).<\/jats:p><\/jats:sec><jats:sec><jats:title>Study design<\/jats:title><jats:p>Twenty\u2010nine patients with melasma were included in a randomized controlled observer\u2010blinded study with split\u2010face design. Each side of the face was randomly allocated to either 4\u20135 non\u2010ablative FLT sessions (15\u2009mJ\/microbeam, 14\u201320% coverage) or TTT (hydroquinone 5%, tretinoin 0.05%, triamcinolone acetonide 0.1% cream). TTT was applied once daily for 15 weeks until the last FLT session. After this last treatment, patients were asked to apply TTT twice weekly on both sides of the face during follow\u2010up. Improvement of melasma was assessed by patient's global assessment (PGA), patient's satisfaction, physician's global assessment (PhGA), melanin index, and lightness (<jats:italic>L<\/jats:italic>\u2010value) at 3 weeks, and at 3 and 6 months after the last treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Mean PGA and satisfaction were significantly lower at the FLT side (<jats:italic>P<\/jats:italic>&lt;0.001). PhGA, melanin index, and <jats:italic>L<\/jats:italic>\u2010value showed a significant worsening of hyperpigmentation at the FLT side. At the TTT side, no significant change was observed. At 6 months follow\u2010up, most patients preferred TTT. Side effects of FLT were erythema, burning sensation, edema, and pain. Nine patients (31%) developed PIH after two or more laser sessions. Side effects of TTT were erythema, burning sensation, and scaling.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Given the high rate of postinflammatory hyperpigmentation, non\u2010ablative 1,550\u2009nm fractional laser at 15\u2009mJ\/microbeam is not recommendable in the treatment of melasma. TTT remains the gold standard treatment. Lasers Surg. Med. 42:607\u2013612, 2010. \u00a9 2010 Wiley\u2010Liss, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/lsm.20937","type":"journal-article","created":{"date-parts":[[2010,9,8]],"date-time":"2010-09-08T16:07:06Z","timestamp":1283962026000},"page":"607-612","source":"Crossref","is-referenced-by-count":59,"title":["Non\u2010ablative 1,550\u2009nm fractional laser therapy versus triple topical therapy for the treatment of melasma: A randomized controlled split\u2010face study"],"prefix":"10.1002","volume":"42","author":[{"given":"Bas S.","family":"Wind","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marije W.","family":"Kroon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arne A.","family":"Meesters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan F.","family":"Beek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P. Wietze","family":"van der Veen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludmila","family":"Nieuweboer\u2010Krobotov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan D.","family":"Bos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Wolkerstorfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,8,25]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630601028778"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.02.009"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1995.01690240119022"},{"key":"e_1_2_6_5_2","first-page":"239","article-title":"Topical tretinoin, hydroquinone, and betamethasone valerate in the therapy of melasma","volume":"23","author":"Gano SE","year":"1979","journal-title":"Cutis"},{"key":"e_1_2_6_6_2","first-page":"67","article-title":"Efficacy and safety of a new triple\u2010combination agent for the treatment of facial melasma","volume":"72","author":"Taylor SC","year":"2003","journal-title":"Cutis"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.12.039"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2007.04.012"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1080\/14764170510037752"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.2310\/6350.2005.31302"},{"key":"e_1_2_6_11_2","article-title":"Non\u2010ablative fractional laser therapy versus triple topical therapy for the treatment of melasma: A randomized controlled pilot study","author":"Kroon MW","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.20048"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1117\/1.2241745"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.20254"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.20591"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1977.tb06132.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(81)70071-9"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07590.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/14764170701418814"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2009.01264.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-007-1458-y"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.20512"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2007.34062.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2005.31933"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.20453"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.9.1139"}],"container-title":["Lasers in Surgery and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flsm.20937","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/lsm.20937","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T04:34:06Z","timestamp":1696912446000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/lsm.20937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,25]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["10.1002\/lsm.20937"],"URL":"https:\/\/doi.org\/10.1002\/lsm.20937","archive":["Portico"],"relation":{},"ISSN":["0196-8092","1096-9101"],"issn-type":[{"value":"0196-8092","type":"print"},{"value":"1096-9101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,25]]}}}